Biocriminology and the Adjudication of Criminal Responsibility: Is There a Consensus Among Scientists' Verdicts?
NCT ID: NCT05007314
Last Updated: 2022-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2021-07-01
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetics of Symptomatology and Treatment Response in Psychotic Major Depression
NCT00691535
Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans
NCT06058702
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
NCT01425671
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697
Impact of Genetic Counseling for Individuals With Mental Illness
NCT00713804
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One hundred sixty participants who completed all study procedures (2 main groups of 80 participants) will be surveyed. A sample size calculation was performed using G\*Power version 3.1.9.4, based on Berryessa and colleagues who conducted a similar survey study in 2021 with comparable outcome measures and analyses. The required effect size is based upon approximately 3-4 outcome measures. The primary research question is between-groups, while secondary ones include within groups measures. Based on the power analysis, a sample of 160 participants will be targeted, which is enough for sufficient power for f = 0.25, power = 0.80, df = 4, for 2 different groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Human Science
Arm 1 will include university graduates that hold at least a science undergraduate degree (or equivalent) in human science, including psychology, neuroscience, human biology, or medicine.
Biocriminological Evidence
Participants in each of the two main groups see a case with and a case without a neurobiological explanation for criminal offending.
Natural or non-science
Arm 2 will include university graduates from non-human or non-scientific fields such as engineering, history, language studies, or law.
Biocriminological Evidence
Participants in each of the two main groups see a case with and a case without a neurobiological explanation for criminal offending.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biocriminological Evidence
Participants in each of the two main groups see a case with and a case without a neurobiological explanation for criminal offending.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Holding a university diploma or equivalent
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Leiden University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mia Athina Thomaidou
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Leiden University
Leiden, South Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-07-16-D.S.V.-V2-3332
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.